|
MED9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.501000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.029700E-02 |
| Normal-vs-Stage2 |
1.124310E-03 |
| Normal-vs-Stage3 |
1.287950E-02 |
| Normal-vs-Stage4 |
2.499200E-03 |
| Stage1-vs-Stage2 |
3.037700E-02 |
| Stage1-vs-Stage3 |
2.848600E-01 |
| Stage1-vs-Stage4 |
5.807800E-02 |
| Stage2-vs-Stage3 |
5.785600E-01 |
| Stage2-vs-Stage4 |
2.639400E-01 |
| Stage3-vs-Stage4 |
1.960610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.977950E-02 |
| Normal-vs-AfricanAmerican |
1.478050E-02 |
| Normal-vs-Asian |
4.261900E-02 |
| Caucasian-vs-AfricanAmerican |
8.292800E-01 |
| Caucasian-vs-Asian |
2.908600E-01 |
| AfricanAmerican-vs-Asian |
2.766800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.264370E-02 |
| Normal-vs-Female |
1.052110E-02 |
| Male-vs-Female |
6.006600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.529860E-02 |
| Normal-vs-Extreme_Weight |
4.803800E-02 |
| Normal-vs-Obese |
1.123570E-02 |
| Normal-vs-Extreme_Obese |
8.815200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.226800E-01 |
| Normal_Weight-vs-Obese |
4.464200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.692750E-01 |
| Extreme_Weight-vs-Obese |
7.555000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.917200E-01 |
| Obese-vs-Extreme_Obese |
3.633600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.131400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.202100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.262400E-03 |
| Normal-vs-Age(81-100Yrs) |
6.036200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.529200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.425800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.762200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.582300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.116200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.726200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.564030E-01 |
| Normal-VS-Type2 PRCC |
2.420200E-04 |
| Normal-VS-KIRP CIMP |
1.489560E-02 |
| Normal-VS-Unclassified PRCC |
9.917800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.13389999999381E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.376100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.624300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.859400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.068200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.061400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.002100E-04 |
| Normal-vs-N1 |
1.983640E-03 |
| Normal-vs-N2 |
7.956600E-03 |
| N0-vs-N1 |
8.012200E-01 |
| N0-vs-N2 |
1.222050E-01 |
| N1-vs-N2 |
9.367700E-02 |
|
|
